These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies. von Bredow B; Arias JF; Heyer LN; Moldt B; Le K; Robinson JE; Zolla-Pazner S; Burton DR; Evans DT J Virol; 2016 Jul; 90(13):6127-6139. PubMed ID: 27122574 [TBL] [Abstract][Full Text] [Related]
44. A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies. Orlandi C; Flinko R; Lewis GK J Immunol Methods; 2016 Jun; 433():51-8. PubMed ID: 26969387 [TBL] [Abstract][Full Text] [Related]
45. Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection. Acharya P; Tolbert WD; Gohain N; Wu X; Yu L; Liu T; Huang W; Huang CC; Kwon YD; Louder RK; Luongo TS; McLellan JS; Pancera M; Yang Y; Zhang B; Flinko R; Foulke JS; Sajadi MM; Kamin-Lewis R; Robinson JE; Martin L; Kwong PD; Guan Y; DeVico AL; Lewis GK; Pazgier M J Virol; 2014 Nov; 88(21):12895-906. PubMed ID: 25165110 [TBL] [Abstract][Full Text] [Related]
46. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection. Ko SY; Pegu A; Rudicell RS; Yang ZY; Joyce MG; Chen X; Wang K; Bao S; Kraemer TD; Rath T; Zeng M; Schmidt SD; Todd JP; Penzak SR; Saunders KO; Nason MC; Haase AT; Rao SS; Blumberg RS; Mascola JR; Nabel GJ Nature; 2014 Oct; 514(7524):642-5. PubMed ID: 25119033 [TBL] [Abstract][Full Text] [Related]
47. The utility of ADCC responses in HIV infection. Chung A; Rollman E; Johansson S; Kent SJ; Stratov I Curr HIV Res; 2008 Nov; 6(6):515-9. PubMed ID: 18991616 [TBL] [Abstract][Full Text] [Related]
48. HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies. McGuire AT; Dreyer AM; Carbonetti S; Lippy A; Glenn J; Scheid JF; Mouquet H; Stamatatos L Science; 2014 Dec; 346(6215):1380-1383. PubMed ID: 25504724 [TBL] [Abstract][Full Text] [Related]
49. Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function. Chung AW; Crispin M; Pritchard L; Robinson H; Gorny MK; Yu X; Bailey-Kellogg C; Ackerman ME; Scanlan C; Zolla-Pazner S; Alter G AIDS; 2014 Nov; 28(17):2523-30. PubMed ID: 25160934 [TBL] [Abstract][Full Text] [Related]
50. Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection. Dugast AS; Stamatatos L; Tonelli A; Suscovich TJ; Licht AF; Mikell I; Ackerman ME; Streeck H; Klasse PJ; Moore JP; Alter G Eur J Immunol; 2014 Oct; 44(10):2925-37. PubMed ID: 25043633 [TBL] [Abstract][Full Text] [Related]
51. Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity. Kramski M; Schorcht A; Johnston AP; Lichtfuss GF; Jegaskanda S; De Rose R; Stratov I; Kelleher AD; French MA; Center RJ; Jaworowski A; Kent SJ J Immunol Methods; 2012 Oct; 384(1-2):51-61. PubMed ID: 22841577 [TBL] [Abstract][Full Text] [Related]
52. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. Haynes BF; Gilbert PB; McElrath MJ; Zolla-Pazner S; Tomaras GD; Alam SM; Evans DT; Montefiori DC; Karnasuta C; Sutthent R; Liao HX; DeVico AL; Lewis GK; Williams C; Pinter A; Fong Y; Janes H; DeCamp A; Huang Y; Rao M; Billings E; Karasavvas N; Robb ML; Ngauy V; de Souza MS; Paris R; Ferrari G; Bailer RT; Soderberg KA; Andrews C; Berman PW; Frahm N; De Rosa SC; Alpert MD; Yates NL; Shen X; Koup RA; Pitisuttithum P; Kaewkungwal J; Nitayaphan S; Rerks-Ngarm S; Michael NL; Kim JH N Engl J Med; 2012 Apr; 366(14):1275-86. PubMed ID: 22475592 [TBL] [Abstract][Full Text] [Related]
53. Humoral signatures of protective and pathological SARS-CoV-2 infection in children. Bartsch YC; Wang C; Zohar T; Fischinger S; Atyeo C; Burke JS; Kang J; Edlow AG; Fasano A; Baden LR; Nilles EJ; Woolley AE; Karlson EW; Hopke AR; Irimia D; Fischer ES; Ryan ET; Charles RC; Julg BD; Lauffenburger DA; Yonker LM; Alter G Nat Med; 2021 Mar; 27(3):454-462. PubMed ID: 33589825 [TBL] [Abstract][Full Text] [Related]
54. Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus. Yucha R; Litchford ML; Fish CS; Yaffe ZA; Richardson BA; Maleche-Obimbo E; John-Stewart G; Wamalwa D; Overbaugh J; Lehman DA Viruses; 2023 Oct; 15(10):. PubMed ID: 37896832 [TBL] [Abstract][Full Text] [Related]
55. Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein. Grunst MW; Ladd RA; Clark NM; Gil HM; Klenchin VA; Mason R; Franchini G; Roederer M; Evans DT PLoS Pathog; 2023 May; 19(5):e1011407. PubMed ID: 37253062 [TBL] [Abstract][Full Text] [Related]
56. Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother. Yaffe ZA; Ding S; Sung K; Chohan V; Marchitto L; Doepker L; Ralph D; Nduati R; Matsen FA; Finzi A; Overbaugh J iScience; 2023 May; 26(5):106762. PubMed ID: 37216090 [TBL] [Abstract][Full Text] [Related]
57. Fibroblast, Epithelial and Endothelial Cell-Derived Human Cytomegalovirus Strains Display Distinct Neutralizing Antibody Responses and Varying Levels of gH/gL Complexes. Fornara C; Schultz E; Lilleri D; Baldanti F; Ryckman B; Gerna G Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901847 [TBL] [Abstract][Full Text] [Related]